# A Comparative Study of KES524 in Patients With Obesity Disease

> **NCT00165685** · PHASE3 · COMPLETED · sponsor: **Eisai Limited**

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Sibutramine Hydrochloride Monohydrate

## Key facts

- **NCT ID:** NCT00165685
- **Lead sponsor:** Eisai Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** — (—)
- **Last updated:** 2010-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00165685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00165685, "A Comparative Study of KES524 in Patients With Obesity Disease". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00165685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*